Percentage of Patients Aged 18 years and Older with a Diagnosis of Heart Failure (HF) With a Current or Prior Left Ventricular Ejection Fraction (LVEF) Less Than or Equal to 40% Who Were Prescribed SGLT-2 Inhibitor Therapy at Hospital Discharge.